Clinical trials
Phase 2 Endometrial Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
297 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 7 |
| 2001 | 8 |
| 2002 | 6 |
| 2003 | 3 |
| 2004 | 6 |
| 2005 | 6 |
| 2006 | 8 |
| 2007 | 14 |
| 2008 | 8 |
| 2009 | 5 |
| 2010 | 8 |
| 2011 | 9 |
| 2012 | 7 |
| 2013 | 2 |
| 2014 | 9 |
| 2015 | 5 |
| 2016 | 8 |
| 2017 | 14 |
| 2018 | 11 |
| 2019 | 16 |
| 2020 | 12 |
| 2021 | 15 |
| 2022 | 15 |
| 2023 | 19 |
| 2024 | 20 |
| 2025 | 18 |
| 2026 | 20 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 124 |
| Recruiting | 52 |
| Unknown status | 32 |
| Not yet recruiting | 27 |
| Active, not recruiting | 25 |
| Terminated | 24 |
| Withdrawn | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 21 |
| M.D. Anderson Cancer Center | 14 |
| Gynecologic Oncology Group | 11 |
| Memorial Sloan Kettering Cancer Center | 9 |
| University of Oklahoma | 8 |
| Dana-Farber Cancer Institute | 7 |
| European Organisation for Research and Treatment of Cancer - EORTC | 5 |
| Merck Sharp & Dohme LLC | 5 |
| Novartis Pharmaceuticals | 5 |
| Peking University People's Hospital | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometrial Neoplasms | 297 |
| Ovarian Neoplasms | 54 |
| Uterine Cervical Neoplasms | 51 |
| Neoplasms | 25 |
| Breast Neoplasms | 23 |
| Fallopian Tube Neoplasms | 19 |
| Uterine Neoplasms | 19 |
| Recurrence | 18 |
| Neoplasm Metastasis | 17 |
| Pancreatic Neoplasms | 16 |
Trials
Showing 26 to 50 of 297. Each trial links to its page on Pharma Observatory.
197 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.